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Berberine is a natural isoquinoline alkaloid with multiple beneficial therapeutic effects. This study was 
designed to evaluate the protective effect of berberine against methotrexate (MTX)-induced oxidative stress 
and inflammation in the brain of rats. Rats received a single intraperitoneal injection of MTX (20 mg/kg) and 
orally administered 25 mg/kg and 50 mg/kg body weight berberine for 7 days. MTX-induced rats showed 
significantly increased lipid peroxidation and nitric oxide levels in the cerebrum. Treatment of the MTX-
induced rats with berberine produced a significant decrease in cerebral levels of lipid peroxidation and nitric 
oxide. In addition, berberine induced a significant increase in reduced glutathione, superoxide dismutase, 
glutathione peroxidase and glutathione-S-transferase in the cerebrum of MTX-induced rats. Rats received MTX 
showed a significant up-regulation of nuclear factor-kappaB (NF-κB), inducible nitric oxide synthase (iNOS), 
tumor necrosis factor alpha (TNF-α) and interleukin-1beta (IL-1β) expression in the cerebrum, an effect that 
was significantly reversed following treatment with berberine. In conclusion, berberine protects against MTX-
induced neurotoxicity through attenuating oxidative stress and inflammation, and boosting the antioxidant 
defenses. 
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INTRODUCTION 
 
The dihydrofolate reductase inhibitor methotrexate 
(MTX) is an anti-metabolite used frequently to treat autoimmune 
diseases and as a chemotherapeutic agent against many types of 
cancer (Ayad et al., 2014, Sakthiswary and Suresh, 2014, Zhu et 
al., 2014). In the treatment of rheumatoid arthritis and psoriasis, 
MTX represents the favored steroid-sparing immunosuppressant 
(Roenigk et al., 1998). Acute, sub-acute, and long-term neuro-
toxicities of MTX have been well-established (Buizer et al., 
2006; Inaba et al., 2008). Disruption of central nervous system 
(CNS) folate homeostasis and/or direct neuronal damage are the 
mechanisms through which MTX exerts neuro-toxicity (Cole         
.   
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et al., 2009; Vezmar et al., 2009). Studies have demonstrated that 
subacute MTX neurotoxicity occurs 2 to 14 days after high-dose or 
prolonged low-dose oral MTX. This neurotoxicity manifests with 
seizures, aphasia, encephalopathy and stroke-like symptoms (Asato 
et al., 1992; Rubnitz et al., 1998). Excessive production of reactive 
oxygen species (ROS) has been implicated in MTX hepatotoxicity, 
nephrotoxicity, intestinal toxicity and cardiotoxicity (Abd El-Twab 
et al., 2016; El-Sheikh et al., 2016; Mahmoud et al., 2017a,b). 
MTX negatively impact the mitochondrial machinery and therefore 
generates excess ROS (Kolli et al., 2014). ROS can initiate 
peroxidation of the cell membranes and damage cellular 
macromolecules leading to cell death (Naik and Panda, 2007). In 
addition, inflammation has been reported to play a central role in 
MTX toxicity (Abd El-Twab et al., 2016; Mahmoud et al., 
2017a,b). The nervous system has a high metabolic rate, high 
levels of polyunsaturated fatty acids and low levels of antioxidants; 
therefore, is vulnerable to damage by oxidative stress (Götz et al.,             
. 
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1994; Barnham et al., 2004). Therefore, mitigating oxidative stress 
can prevent MTX toxicity to different body organs.  
Berberine (BBR) is a natural isoquinoline alkaloid that 
can be isolated from Coptis chinensis (Teodoro et al., 2013). 
Previous work from our lab showed the protective effect of BBR 
against oxidative stress in animal models of diabetes (Mahmoud et 
al., 2017c) and hepatotoxicity (Germoush and Mahmoud, 2014; 
Mahmoud et al., 2014; Mahmoud et al., 2017b). Therefore, this 
study was designed to evaluate the protective effect of BBR 
against MTX-induced cerebral oxidative stress and inflammation 
in rats. 
 
MATERIALS AND METHODS 
 
Chemicals 
MTX was supplied by Shanxi PUDE Pharmaceutical 
Company (Shanxi, China). BBR, reduced glutathione (GSH), 5,5'-
dithiobis-(2-nitrobenzoic acid), trichloroacetic acid, pyrogallol, 2-
(1-naphthylamino) ethylamine dihydrochloride, sulfanilamide, 
thiobarbituric acid and 1,1,3,3 tetramethoxypropane were 
purchased from Sigma (St. Louis, MO, USA). All other chemicals 
were of analytical grade and were supplied by standard suppliers. 
 
Experimental animals and treatments 
Twenty-four male Wistar rats weighing between 130–
150 g were used in the present investigation. The animals were 
obtained from the National Institute of Ophthalmology (Giza, 
Egypt) and were housed in well-aerated standard cages at normal 
atmospheric temperature (22 ± 2°C) and normal 12 h light/dark 
cycle. They were given a free access to a standard pellet diet and 
water ad libitum. All animal procedures were approved by the 
Institutional Ethics Committee of Beni-Suef University (Egypt). 
The animals were divided into 4 groups, each comprising 
6 rats (N = 6) as following: 
Group I (Control): rats received a single intraperitoneal (ip) 
injection of physiological saline and orally administered 
the vehicle 0.5% carboxymethyl cellulose (CMC) for 7 
consecutive days. 
Group II (MTX): rats received a single ip injection of MTX (20 
mg/kg) dissolved in saline (Mahmoud et al., 2017a) and 
orally administered 0.5% CMC for 7 consecutive days. 
Group III (MTX + 25 mg BBR): rats received a single ip 
injection of MTX (20 mg/kg) and orally administered 25 
mg/kg BBR (Mahmoud et al., 2014) dissolved in 0.5% 
CMC for 7 consecutive days. 
Group IV (MTX + 50 mg BBR): rats received a single ip injection 
of MTX (20 mg/kg) and orally administered 50 mg/kg 
BBR (Mahmoud et al., 2014) dissolved in 0.5% CMC for 
7 consecutive days. 
 
Samples collection and preparation 
At the end of experiment, all rats were sacrificed under 
light ether anesthesia and the brain was quickly removed and 
rinsed with ice-cold saline. The cerebrum was dissected and kept 
frozen in liquid nitrogen. Frozen cerebrum samples (10%w/v) 
were homogenized in cold phosphate-buffered saline, centrifuged 
and the clear supernatant was collected and stored at -80°C to 
assay malondialdehyde (MDA), nitric oxide (NO), GSH, 
superoxide dismutase (SOD), glutathione peroxidase (GPx) and 
glutathione-S-transferase (GST). Other samples from the cerebrum 
were collected on RNA later and kept at -80°C for RNA isolation. 
 
Determination of lipid peroxidation, NO and antioxidant 
defenses 
Lipid peroxidation was determined in the cerebrum 
homogenate by assaying the level of MDA according to the 
method of Preuss et al (1998). NO level was assayed following the 
method of Grisham et al (1996), and GSH content was determined 
according to the method of Beutler et al (1963). SOD, GPx and 
GST were measured according to the methods of Marklund and 
Marklund (1974), Matkovics et al (1998) and Mannervik and 
Gutenberg (1981) respectively. 
 
Quantitative reverse transcriptase real time polymerase chain 
reaction (qRT-PCR) 
To determine the effect of BBR on MTX-induced 
inflammation, the gene expression levels of nuclear factor-kappaB 
(NF-κB), inducible nitric oxide synthase (iNOS) and tumor 
necrosis factor alpha (TNF-α) were assayed using PCR as we 
previously reported (Mahmoud, 2014). Total RNA was isolated 
from the frozen cerebrum samples using Trizol reagent 
(Invitrogen, USA). Isolated RNA was treated with DNase I 
(Thermo Scientific, USA) and quantified at 260 nm. RNA samples 
with A260/280 nm ratio of 1.8 or more were selected and the 
integrity was further confirmed using formaldehyde-agarose gel 
electrophoresis. Two µg RNA was reverse transcribed into first 
strand cDNA using RT kit (Thermo Scientific, USA). cDNA was 
amplified using SYBR green master mix (Thermo Scientific, 
USA) and the primer pairs listed in Table 1.  
 
Table 1: Primers used in qRT-PCR. 
Gene 
GenBank 
Accession 
Number 
Sequence (5'-3') 
A
m
p
li
c
o
n
 
S
iz
e 
(b
p
) 
NF-κB NM_199267.2 F: TCTCAGCTGCGACCCCG 
R: TGGGCTGCTCAATGATCTCC 
122 
iNOS NM_012611.3 F: ATTCCCAGCCCAACAACACA 
R: GCAGCTTGTCCAGGGATTCT 
112 
TNF-α XM_008772775
.2 
F: AAATGGGCTCCCTCTCATCAGTTC 
R: TCTGCTTGGTGGTTTGCTACGAC 
111 
IL-1β NM_031512.2 F: GACTTCACCATGGAACCCGT 
R: CAGGGAGGGAAACACACGTT 
200 
Β-Actin NM_031144.3 F: AGGAGTACGATGAGTCCGGC 
R: CGCAGCTCAGTAACAGTCCG 
71 
 
The qPCR reactions included 10 min initial denaturation 
at 95°C and 40 cycles each consists of 30 sec denaturation at 95°C, 
annealing for 60 sec and extension at 72°C for 30 sec. The 2
-∆∆Ct
 
method (Livak and Schmittgen, 2011) was used to analyze the 
amplification data and results were normalized to β-actin. 
 Hozayen  et al. / Journal of Applied Pharmaceutical Science 7 (11); 2017: 043-049                                          045 
 
Statistical analysis 
Statistical analysis was performed using GraphPad Prism 
5 software (GraphPad Software, San Diego, CA). Results were 
expressed as mean ± standard error of the mean (SEM) and all 
statistical comparisons were made by means of the one-way 
ANOVA test followed by Tukey’s test post hoc analysis. A P 
value <0.05 was considered significant. 
 
RESULTS 
 
Berberine attenuates lipid peroxidation and NO generation in 
the cerebrum of MTX-induced rats 
MTX administration induced a significant (P<0.001) 
increase in the lipid peroxidation marker MDA in the cerebrum 
when compared with the control group (Fig. 1). Rats received 25 
mg/kg body weight berberine showed a significant (P<0.001) 
decrease in lipid peroxidation levels in the cerebrum. Similarly, 
MTX-induced rats treated with 50 mg/kg berberine exhibited 
significantly (P<0.001) declined cerebral lipid peroxidation levels 
as depicted in Figure 1. 
 
 
Fig. 1: Berberine attenuates lipid peroxidation in the cerebrum of 
MTX-induced rats. Data are Mean ± SEM. Number of animals in each 
group is six. ***P<0.001 versus Control and †††P<0.001 versus 
MTX. MDA, malondialdehyde; BBR, berberine. 
 
 
Fig. 2: Berberine reduces nitric oxide levels in the cerebrum of MTX-
induced rats. Data are Mean ± SEM. Number of animals in each group 
is six. ***P<0.001 versus Control and †††P<0.001 versus MTX. NO, 
nitric oxide; BBR, berberine. 
 
MTX-induced rats showed a significant (P<0.001) 
increase in NO levels   when   compared   with   the   control   rats  
 
 
(Fig. 2). Treatment with berberine at doses of 25 and 50 mg/kg 
body weight produced a significant (P<0.001) decrease in cerebral 
levels of NO in MTX-administered rats when compared with the 
untreated MTX-induced rats (Fig. 2). 
 
 
Berberine increases GSH content in the cerebrum of MTX-
induced rats 
Analysis of the cerebral GSH content showed a 
significant (P<0.001) decrease in MTX-induced rats when 
compared with the control group (Fig. 3). MTX-induced rats 
received 25 mg/kg body weight berberine showed a significant 
(P<0.001) increase in cerebral GSH content. Similarly, the higher 
berberine dose significantly (P<0.001) prevented MTX-induced 
GSH decline in the cerebrum of rats  (Fig. 3). 
 
 
 
 
Fig. 3: Berberine increases reduced glutathione in the cerebrum of 
MTX-induced rats. Data are Mean ± SEM. Number of animals in each 
group is six. ***P<0.001 versus Control and †††P<0.001 versus 
MTX. GSH, reduced glutathione; BBR, berberine. 
 
 
Berberine enhances the activity of antioxidant enzymes in the 
cerebrum of MTX-induced rats 
We determined the effect of berberine on the antioxidant 
defenses SOD, GPx and GST in the cerebrum of MTX-induced 
rats as represented in Figure 4. 
MTX administration produced a significant                 
(P<0.001) decline in the activity of cerebral SOD when               
compared with the control group of rats (Fig. 4A).                    
MTX-induced rats received either 25 or 50 mg/kg body                  
weight berberine showed a significant (P<0.001) increase in SOD 
activity. 
GPx and GST showed a similar pattern where MTX-
induced rats exhibited a significant (P<0.001) decrease in their 
activity in the cerebrum. On the other hand, MTX-induced rats 
received berbeine at doses of 25 and 50 mg/kg body weight 
showed significantly (P<0.001) increased activity of cerebral GPx 
(Fig. 4B) and GST (Fig. 4C). 
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Fig. 4: Berberine enhances the activity of antioxidant enzymes in the 
cerebrum of MTX-induced rats. Data are Mean ± SEM. Number of 
animals in each group is six. ***P<0.001 versus Control and 
†††P<0.001 versus MTX. SOD, superoxide dismutase; GPx, 
glutathione peroxidase; GST, glutathione-S-transferase; BBR, 
berberine. 
 
Berberine down-regulates NF-κB, iNOS and pro-inflammatory 
cytokines in the cerebrum of MTX-induced rats 
To evaluate the protective effect of berberine against 
MTX-induced inflammation in the cerebrum of rats, we 
determined the gene expression levels of NF-κB, iNOS, TNF-α 
and IL-1β. Rats received MTX showed a significant (P<0.001) up-
regulation in NF-κB gene expression when compared with the 
control rats as depicted in Figure 5A. Similarly, iNOS gene 
expression was significantly (P<0.001) up-regulated in the 
cerebrum of MTX-induced rats when compared with the control 
group (Fig. 5B). MTX-induced rats treated with berberine at doses 
of 25 and 50 mg/kg body weight showed a significant (P<0.001) 
down-regulation of NF-κB (Fig. 5A) and iNOS (Fig. 5B) mRNA 
expression in the cerebrum. Gene expression of the pro-
inflammatory cytokines TNF-α (Fig. 6A) and IL-1β (Fig. 6B) 
showed a significant (P<0.001) increase in their mRNA levels in 
the cerebrum of MTX-induced rats when compared with the 
control group. On the other hand, MTX-induced rats received 25 
and 50 mg/kg body weight berberine exhibited a significant 
(P<0.001) down-regulation in mRNA expression levels of cerebral 
TNF-α and IL-1β. 
 
 
 
Fig. 5: Berberine down-regulates (A) nuclear factor-kappaB (NF-κB) 
and (B)inducible nitric oxide synthase (iNOS) expression in the 
cerebrum of MTX-induced rats. Data are Mean ± SEM. Number of 
animals in each group is six. ***P<0.001 versus Control and 
†††P<0.001 versus MTX.BBR, berberine. 
 
 
 
Fig. 6: Berberine down-regulates (A) tumor necrosis factor alpha 
(TNF-α) and (B) interleukin-1beta (IL-1β) expression in the cerebrum 
of MTX-induced rats. Data are Mean ± SEM. Number of animals in 
each group is six. ***P<0.001 versus Control and †††P<0.001 versus 
MTX.BBR, berberine. 
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DISCUSSION 
 
The present study demonstrated the protective effect of 
the natural isoquinoline alkaloid berberine on MTX-induced 
neurotoxicity in rats. Berberine prevented oxidative/nitrosative 
stress, enhanced the antioxidant defenses and mitigated 
inflammation in the cerebrum of MTX-induced rats. 
Oxidative stress and surplus production of ROS have 
been reported to play a central role in the toxicity of MTX (Abd 
El-Twab et al., 2016; El-Sheikh et al., 2016; Mahmoud et al., 
2017a,b). The mechanism of excessive ROS generation by MTX 
involves its negative impact on the mitochondrial machinery (Kolli 
et al., 2014) and declined antioxidant defenses (Abd El-Twab et 
al., 2016; Mahmoud et al., 2017a,b). Possible mechanisms of 
excessive ROS generation involve the increased activity of purine-
catabolizing enzymes adenosine deaminase (ADA) and xanthine 
oxidase (XO). Impaired function of the mitochondrial membrane 
leads to impaired ATP metabolism with increased production of 
purine degradation products such as adenosine, inosine 
hypoxanthine and xanthine which are substrates for ADA and XO 
(Fadillioglu et al., 2003). ROS are well-known to elicit 
peroxidation of the membranous lipids, damage DNA and 
proteins, and subsequently leading to cell death (Naik and Panda, 
2007). The nervous system is particularly vulnerable to oxidative 
damage because of its high metabolic rate, high levels of 
polyunsaturated fatty acids and low levels of antioxidants (Götz et 
al., 1994; Barnham et al., 2004). 
Here, MTX-induced rats showed a significant increase in 
cerebral lipid peroxidation and NO levels. NO can react with 
superoxide radical to produce the versatile and potent oxidizing 
agent peroxynitrite which induces further cell damage (McKim et 
al., 2003). Interestingly, treatment with berberine markedly 
prevented MTX-induced lipid peroxidation and increased 
production of NO. In this context, berberine has been shown to 
protect against oxidative stress and memory impairment in a rat 
model of streptozotocin-induced diabetes (Bhutada et al., 2011). In 
rats with nonalcoholic steatohepatitis, Ghareeb et al. (2015) 
reported the ability of berberine to reduce oxidative stress and 
neurotoxicity. In this study, berberine decreased lipid peroxidation 
and increased the antioxidant defenses in the brain tissue of rats.In 
addition, the study of Siow et al. (2011) demonstrated that 
berberine quenches superoxide anions and NO, and exerts radical 
scavenging activity against the high reactive peroxynitrite and 
hydroxyl radicals. In cell based systems, berberine showed a 
potent inhibitory effect on ROS production (Hur et al., 2009) and 
prevented Nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidase mediated superoxide production in lipopolysaccharide 
(LPS)-stimulated human monocyte-derived macrophages (Sarna et 
al., 2010). Furthermore, Srikanth et al. (2011) reported that 
berberine inhibits NO production LPS-stimulated murine 
macrophages by inhibiting iNOS expression. Furthermore, 
previous work from our lab demonstrated that berberine 
suppressed lipid peroxidation and reduced NO levels in rat models 
of drug-induced liver injury (Germoush and Mahmoud, 2014; 
Mahmoud et al., 2014) and type 2 diabetes (Mahmoud et al., 
2017c). MTX administration significantly reduced the antioxidants 
GSH, SOD, GPx and GST in the cerebrum of rats. These findings 
support our recent studies where we reported declined non-
enzymatic and enzymatic antioxidants in MTX-induced rats 
(Mahmoud et al., 2017a,b). GSH is the most important cellular 
antioxidant for protecting against ROS and other oxidizing agents 
(Franco et al., 2007). GSH is the substrate for GPx that works with 
SOD, GST and other enzymes to protect the cell against the 
deleterious effects of ROS (Wei et al., 2011). The significant 
depletion of GSH induced by MTX administration might be the 
cause of reduced effectiveness of the antioxidant enzyme defense 
system, and therefore, sensitizing the cells to ROS (Babiak et al., 
1998). A recent study by Moore et al. (2016) demonstrated down-
regulated SOD in different regions of the brain of methotrexate-
treated rats. In addition, research from our laboratory showed a 
significant decline in GSH, SOD, GPx and GST in the kidney and 
liver of MTX-induced rats. 
In the present study, MTX-induced rats received 
berberine exhibited significant amelioration in cerebral GSH, 
SOD, GPx and GST. Different studies have demonstrated the 
ameliorative effect of berberine on antioxidants in different tissue 
and organs in rats. We have previously reported that berberine 
enhances antioxidant defenses in liver of diabetic (Mahmoud et 
al., 2017c) and cyclophosphamide- (Germoush and Mahmoud, 
2014), isoniazid/rifampicin- (Mahmoud et al., 2014) and MTX-
induced rats (Mahmoud et al., 2017b). Therefore, we assume that 
the antioxidant efficacy of berberine plays a central role in its 
neuroprotective effect. In this context, we have recently shown the 
potential of antioxidants to protect against neurotoxicity in rats 
(Mahmoud and Abd El-Twab, 2017). 
In addition to oxidative stress, inflammation is a central 
contributing factor in MTX-induced toxicity. In the present study, 
administration of MTX induced a significant up-regulation of NF-
κB and iNOS. NF-κB is a redox-sensitive transcription factor that 
can be activated as a result of increased ROS production (Matata 
and Galiñanes, 2002). Activated NF-κB elicits the transcription of 
genes of many inflammatory mediators suck as iNOS, TNF-α and 
IL-1β. Here, the gene expression levels of iNOS, TNF-α and IL-1β 
were significantly up-regulated in the cerebrum of MTX-induced 
rats, demonstrating an inflammatory insult. In support of our 
findings, we have recently reported that the administration of 
MTX provoked inflammation in rats as evidenced by increased 
circulating levels of the pro-inflammatory cytokines (Abd El-
Twab et al., 2016; Mahmoud et al., 2017a,b). 
Berberine supplemented MTX-induced rats showed 
declined expression of NF-κB, iNOS, TNF-α and IL-1β in the 
cerebrum, pointing to a potent anti-inflammatory efficacy of 
berberine. Previous work from our laboratory showed that 
berberine prevents inflammation in diabetic (Mahmoud et al., 
2017c) and cyclophosphamide- (Germoush and Mahmoud, 2014), 
isoniazid/rifampicin- (Mahmoud et al., 2014) and MTX-induced 
rats (Mahmoud et al., 2017b). The antioxidant and anti-
inflammatory mechanism of berberine involves activation of the 
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nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and peroxisome 
proliferator activated receptor gamma (PPARγ) as we previously 
demonstrated (Mahmoud et al., 2014, 2017b,c). Nrf2 induces the 
transcription of antioxidative genes, (Jaiswal, 2004), and has been 
implicated in the control of inflammation. Nrf2 activation is 
associated with down-regulation of NF-κB and iNOS (Mahmoud 
and Al Dera, 2015) and decreased production of pro-inflammatory 
cytokines (Mahmoud and Al Dera, 2015, Kamel et al., 2016; 
Mahmoud et al., 2017a,b,d,e). In addition, PPARγ activation 
modulates the expression of several antioxidant genes (Girnun et 
al., 2002, Chung et al., 2009) and induce anti-inflammatory 
responses (Yu et al., 2002).  
In conclusion, the isoquinoline alkaloid berberine 
berberine prevented MTX-induced oxidative stress and 
inflammation in the cerebrum of rats. Berberine enhanced the non-
enzymatic and enzymatic antioxidants in the cerebrum of MTX-
induced rats. However, further studies are required to determine 
the exact neuroprotective mechanism of berberine. 
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